Clinical trial

Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis

NCT02087696

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Tocilizumab Normalized identity: tocilizumabView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-05-01

PhasePHASE4

Conditions

Arthritis, Rheumatoidunresolved

Interventions

TocilizumabDRUG · verified · RxNorm: tocilizumab

Sponsors & collaborators

Spanish Foundation of Rheumatologylead sponsor

Roche Farma, S.Acollaborator

Mapped research locations

MadridMadrid, Spain1 BarcelonaBarcelona, Spain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02087696 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.